Early-phase expansion in an age of cut backs
30 June 2011 | Jonathan Hare Scrip Clinical Research
FDA Warning Eclipses Sun, SPARC But Investors Stand Pat Pfizer Pain Cutback Shutters UK R&D Site GE Spin-Off Wins US Approval For Prostate Cancer PET Tracer Opko Blames Rayaldee Snub On Manufacturer
Other Features & Analysis
Brexit: What Now For Device Notified Bodies, CE Marks And The Future MDR/IVDR? Buzzing Indian M&A/IPO Counter In 2016? Pfizer Inversion Infuriates Politicians; Trigger Tax Fix Needs? Is the Biotech IPO Window Closing?